Lindbrook Capital, LLC
- SEC CIK
- 0001767045
- Latest filing
- May 5, 2025
DYN holding history
Dyne Therapeutics, Inc. in every 13F filed by Lindbrook Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DYN overviewAll 13F holders of DYNFull Q1 2025 holdings
- Shares (Q1 2025)
- 629
- Value
- $6.58K
- % of portfolio
- <0.1%
- Quarters held
- 12
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 629 | $6.58K | <0.1% | +410+187.2% | Added | Holders |
| Q4 2024 | 219 | $5.16K | <0.1% | −105−32.4% | Reduced | Holders |
| Q3 2024 | 324 | $11.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 324 | $11.4K | <0.1% | +183+129.8% | Added | Holders |
| Q1 2024 | 141 | $4.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 141 | $1.88K | <0.1% | +5+3.7% | Added | Holders |
| Q3 2023 | 136 | $1.22K | <0.1% | +33+32.0% | Added | Holders |
| Q2 2023 | 103 | $1.16K | <0.1% | −117−53.2% | Reduced | Holders |
| Q1 2023 | 220 | $2.53K | <0.1% | +117+113.6% | Added | Holders |
| Q4 2022 | 103 | $1.19K | <0.1% | −84−44.9% | Reduced | Holders |
| Q3 2022 | 187 | $2.00K | <0.1% | +187 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −437−100.0% | Sold out | Holders |
| Q1 2022 | 437 | $4.00K | <0.1% | +437 | New | Holders |